A detailed history of Stablepoint Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Stablepoint Partners, LLC holds 50,056 shares of MRK stock, worth $6.3 Million. This represents 1.34% of its overall portfolio holdings.

Number of Shares
50,056
Previous 43,412 15.3%
Holding current value
$6.3 Million
Previous $4.73 Billion 39.56%
% of portfolio
1.34%
Previous 1.21%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$113.24 - $131.95 $752,366 - $876,675
6,644 Added 15.3%
50,056 $6.6 Billion
Q4 2023

Feb 12, 2024

BUY
$100.18 - $109.02 $4.35 Million - $4.73 Million
43,412 New
43,412 $4.73 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $319B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Stablepoint Partners, LLC Portfolio

Follow Stablepoint Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stablepoint Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stablepoint Partners, LLC with notifications on news.